Targeting the NLRP3 inflammasome with natural products for ischemia–reperfusion injury across organs: mechanisms, structure–activity relationships, and delivery innovations

Oct 17, 2025Inflammopharmacology

Natural compounds targeting the NLRP3 immune sensor to reduce damage from blood flow loss and restoration in different organs: how they work, chemical features, and delivery methods

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗

Abstract

Natural products targeting the NLRP3 inflammasome may mitigate ischemia/reperfusion (I/R) injury across multiple organs.

Excessive activation of the NLRP3 inflammasome is linked to inflammation, cytokine release, and tissue damage in I/R injury.
Phytochemicals such as glycyrrhizin, curcumin, and resveratrol may inhibit NLRP3 activation through various mechanisms, including caspase-1 activation and oxidative stress pathways.
Challenges in using these natural compounds include poor bioavailability and rapid metabolism.
Innovative formulation strategies, like lipid nanoparticles and mesoporous silica nanoparticles, could enhance the delivery and effectiveness of these phytochemicals.
In vitro and in vivo studies indicate that these compounds may reduce infarct size and promote cell survival after I/R injury.

AI simplified

The review provides a comprehensive study of the therapeutic potential of natural products targeting the NLRP3 inflammasome to mitigate ischemia/reperfusion (I/R) injury across multiple organs. Excessive activation of the NLRP3 inflammasome triggers inflammatory cascades, cytokine release, pyroptosis, and tissue damage that exacerbate I/R injury in conditions such as ischemic stroke, myocardial infarction, and organ transplantation. It emphasizes the central pathological role of NLRP3 inflammasome activation in I/R injury and the critical need for effective inhibitors. It systematically presents pharmacological mechanisms of various phytochemicals-including glycyrrhizin, isoliquiritigenin, celastrol, colchicine, curcumin, quercetin, ferulic acid, and resveratrol-and their specific inhibitory actions on NLRP3 via ASC oligomerization, caspase-1 activation, NF-κB signaling, ROS production, and potassium efflux pathways. The manuscript also discusses challenges related to poor bioavailability and rapid metabolism of these natural compounds. It outlines innovative formulation strategies, including lipid nanoparticles, liposomes, polymeric carriers, and mesoporous silica nanoparticles, which enhance pharmacokinetics, stability, targeted delivery, and blood-brain barrier penetration, thereby amplifying therapeutic efficacy. In vitro and in vivo studies consistently show that these phytoconstituents reduce infarct size, inflammatory cytokine levels, oxidative stress, and pyroptosis, promoting cell survival and functional recovery after I/R injury. The review underscores the translational promise of combining traditional medicinal knowledge with advanced nanotechnology to develop safer and more effective multi-targeted therapies for I/R-related diseases. Overall, this manuscript highlights natural NLRP3 inflammasome inhibitors as a promising therapeutic paradigm that merits further clinical development to address the unmet needs in I/R injury management.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

Targeting the NLRP3 inflammasome with natural products for ischemia–reperfusion injury across organs: mechanisms, structure–activity relationships, and delivery innovations

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief